This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Indian Institute of Science. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Vamsee V Aditya Mallajosyula: Innovator in Influenza Research
Introduction
Vamsee V Aditya Mallajosyula is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of biomedical research, particularly in the development of innovative solutions for combating influenza.
Latest Patents
Vamsee holds a patent titled "Polypeptides for generating anti-influenza antibodies and uses thereof." This patent describes a polypeptide that comprises hemagglutinin stem domain fragments capable of eliciting broadly cross-reactive anti-influenza antibodies. The invention aims to confer protection against the influenza virus. The disclosure also outlines a method for preparing the polypeptide, enhancing its immunogenic properties through specific biochemical and biophysical characteristics. Additionally, it includes recombinant DNA constructs, vectors, and host cells that contain the nucleic acid encoding the polypeptide, along with its applications in the prevention and detection of influenza.
Career Highlights
Vamsee is affiliated with the Indian Institute of Science, where he conducts research and develops innovative solutions in the field of immunology. His work has garnered attention for its potential impact on public health, particularly in the prevention of influenza outbreaks.
Collaborations
Vamsee collaborates with Raghavan Varadarajan, a fellow researcher, to advance their shared goals in the field of influenza research. Their partnership exemplifies the importance of teamwork in scientific innovation.
Conclusion
Vamsee V Aditya Mallajosyula is a dedicated inventor whose work in developing polypeptides for anti-influenza antibodies showcases his commitment to improving public health. His contributions are vital in the ongoing fight against influenza, and his innovative research continues to pave the way for future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
